MAAT INDEX

CLAIM #12213 · Bristol-Myers Squibb Company (BMY) · 2025Q3 earnings call · Oct 30, 2025 · due Nov 30, 2025

We believe that this -- the price will be made public at the latest, November 30.

Adam Lenkowsky · Chief Commercialization Officer

CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
We believe that this -- the price will be made public at the latest, November 30.
Reported
Recall the IRA price was effectuated January 1, and this includes the removal of the Medicare Part D liability both in the initiation and in the catastrophic phase.

Verify independently

SEC filings for BMY · Claim quote is verbatim from the 2025Q3 earnings call.